口服葡萄糖耐量试验血糖曲线形态预测青少年2型糖尿病血糖失败率
在TODAY研究队列中,随机化时OGTT血糖曲线分为单相、双相和持续上升三型。持续上升组β细胞功能更低,血糖失败率更高(58.3% vs 42.3% vs 39.1%,P<0.0001),且6个月内C肽指数和oDI下降幅度最大。OGTT曲线形态可作为预测治疗反应的代谢生物标志物。
要点
- OGTT持续上升型曲线提示β细胞功能受损更重。
- 持续上升型血糖失败率最高,双相型最低。
- 曲线形态可独立于病程和治疗方案预测β细胞功能下降。
核心结论
- 在TODAY研究队列中,随机化时OGTT血糖曲线呈持续上升型反映β细胞功能降低,并预示更高的血糖失败率和更快的β细胞功能恶化,且独立于糖尿病病程和治疗分组。
- OGTT血糖曲线形态可能作为预测青少年2型糖尿病治疗反应的代谢生物标志物。
研究设计与样本
- TODAY研究队列分析,纳入随机化时进行的OGTT共662例。
- 将OGTT血糖曲线分为单相、双相和持续上升三型,比较三组间 demographics、胰岛素敏感性(1/空腹胰岛素)、C肽指数(△C30/△G30)及β细胞功能相对胰岛素敏感性(口服处置指数oDI)。
主要发现
- 随机化时21.7%为持续上升型,68.6%为单相型,9.7%为双相型。
- 持续上升组胰岛素敏感性与另两组相似,但C肽指数和oDI显著更低,尽管糖尿病病程相似。
- 血糖失败率:持续上升组58.3%,单相组42.3%,双相组39.1%(P < 0.0001)。
- 6个月C肽指数下降幅度:持续上升组32.8%,单相组18.1%,双相组13.2%;oDI下降幅度:持续上升组32.2%,单相组11.6%,双相组9.1%;胰岛素敏感性无差异。
临床怎么用
- 对青少年2型糖尿病患者可关注OGTT血糖曲线形态,持续上升型提示β细胞功能更差、血糖失败风险更高。
- 曲线形态有助于在治疗早期识别可能对治疗反应不佳的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Obese youth without diabetes with monophasic oral glucose tolerance test (OGTT) glucose response curves have lower insulin sensitivity and impaired β-cell function compared with those with biphasic curves. The OGTT glucose response curve has not been studied in youth-onset type 2 diabetes. Here we test the hypothesis that the OGTT glucose response curve at randomization in youth in the TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth) study forecasts heightened glycemic failure rates and accelerated decline in β-cell function. RESEARCH DESIGN AND METHODS: OGTTs (n = 662) performed at randomization were categorized as monophasic, biphasic, or incessant increase. Demographics, insulin sensitivity (1/fasting insulin), C-peptide index (△C30/△G30), and β-cell function relative to insulin sensitivity (oral disposition index [oDI]) were compared among the three groups. RESULTS: At randomization, 21.7% had incessant increase, 68.6% monophasic, and 9.7% biphasic glucose response curves. The incessant increase group had similar insulin sensitivity but significantly lower C-peptide index and lower oDI, despite similar diabetes duration, compared with the other two groups. Glycemic failure rates were higher in the incessant increase group (58.3%) versus the monophasic group (42.3%) versus the biphasic group (39.1%) (P < 0.0001). The 6-month decline in C-peptide index (32.8% vs. 18.1% vs. 13.2%) and oDI (32.2% vs. 11.6% vs. 9.1%) was greatest in incessant increase versus monophasic and biphasic with no difference in insulin sensitivity. CONCLUSIONS: In the TODAY study cohort, an incessant increase in the OGTT glucose response curve at randomization reflects reduced β-cell function and foretells increased glycemic failure rates with accelerated deterioration in β-cell function independent of diabetes duration and treatment assignment compared with monophasic and biphasic curves. The shape of the OGTT glucose response curve could be a metabolic biomarker prognosticating the response to therapy in youth with type 2 diabetes.
引用
- Arslanian S, El Ghormli L, Young Kim J, et al. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in β-Cell Function in TODAY. Diabetes Care. 2018. PMID: 30455329. doi:10.2337/dc18-1122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。